Aceragen Inc (ACGN) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aceragen Inc   (NASDAQ: ACGN)


Aceragen Inc's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aceragen Inc's ROI in the first quarter of 2023?
Aceragen Inc recorded a cumulative net loss of $-41 million during 12 months ending in the first quarter of 2023, resulting in a negative return on investment (ROI) of -66.66%.

Within the Healthcare sector 749 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2022 from 3929 to 4521.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM 91.95 % 46.23 % 13.83 % -17.12 % 3.98 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 61 80 84 22 26
Return On Investment (TTM) -66.66 % -44.07 % -28.88 % -52.32 % -52.5 %
ACGN's Overall Ranking # 4521 # 3929 # 0 # 0 # 0
Seq. Investment Change TTM 16.17 % 30.6 % 45.58 % -13.1 % -11.5 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -41 -23 -12 -15 -17

ACGN Company Profile >> Back to ACGN Roi Comparisons >> See Annual ACGN Return On Investment



Return On Investment ACGN's Ranking
Within: No.
Industry # 121
Sector # 750
Overall # 4521

Return On Investment Statistics
High Average Low
298.61 %
-58.2 %
-487.09 %
(Mar 31 2021)   (Sep 30 2020)







Financial Statements
Aceragen Inc's I. Quarter Investments $ 61 Millions ACGN's Balance sheet
Aceragen Inc's I. Quarter Income $ -22 Millions Quarterly ACGN's Income Statement
ACGN's Income by Division See ACGN's Income by Division


ACGN Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 80 30 28 -7 64
Y / Y Investment Growth 165.6 % 8.58 % - - -40.9 %
Net Income in Millions -23 97 -113 -57 -60
Y / Y Net Income Growth - - - - -
Annual Return On Investment -29.32 % 323.12 % -407.74 % - -93.56 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ACGN's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ACGN's Competitors
Subscribers only: Roi for Aceragen Inc's Suppliers
Subscribers only: Return On Investment for ACGN's Customers

Other Ratios
ACGN's Roa ACGN's Inventory Turnover Ratio ACGN's Growth Rates ACGN's Dividend Statistics
ACGN's Profitability Ratios ACGN's Asset Turnover Ratio ACGN's Dividend Growth
ACGN's Roe ACGN's Valuation Ratios ACGN's Financial Strength Ratios ACGN's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.